Publications

Shrestha AC, Field E, Thangarajah D, Andrews R, Ware RS, Lambert SB. Influenza epidemiology and vaccine effectiveness following funded influenza vaccine in Queensland, Australia, 2022. Influenza & Other Respiratory Viruses 2024;18:e70007. doi: 10.1111/irv.70007. [Full text]

Wang X, Patel C, Giles ML, Burns P, Macartney K, Teh B, Williams PC. Glucocorticoid dosing and implications for vaccination: evolution of global definitions. Clinical Infectious Diseases 2024:ciae613. doi: 10.1093/cid/ciae613 . [Full text]

Misan A, Lambert SB, Phung H, Young MK. Evaluation of the Queensland JEV vaccine program response to the 2022 Australian outbreak. Epidemiology & Infection 2024;152:e176. doi: 10.1017/S0950268824001730. [Full text]

Mazzocato P, Leder K, Deng L, Britton PN. Travel-associated illness in children in pre-pandemic Western Sydney, 2018-2020. Public Health Research and Practice 2024;34:3432422. doi: 10.17061/phrp3432422. [Full text]

Patel C, Vette K, Dalton L, Dey A, Hendry A, Hull B, McIntyre P, Macartney K, Beard F. Assessment of the first 5 years of pharmacist-administered vaccinations in Australia: learnings to inform expansion of services. Public Health Research and Practice 2024;34:3432420. doi: 10.17061/phrp3432420. [Full text]

Tinessia A, Clark K, Randell M, Leask J, King C. Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review. Global Health Action 2024;17:2384497. doi: 10.1080/16549716.2024.2384497. [Full text]

Loe MW, Soenong H, Lee E, Li-Kim-Moy J, Williams PC, Yeo KT. Nirsevimab: alleviating the burden of RSV morbidity in young children. Journal of Paediatrics and Child Health 2024;60:489-498. doi: 10.1111/jpc.16643. [Full text]

McDonald E, Pittet LF, Barry SE, Bonten M, Campbell J, Croda J, Croda MG, Dalcolmo MP, Davidson A, de Almeida E Val FF, Dos Santos MG, Gardiner MK, Gell MG, Gwee A, Krastev MA, Lacerda MVG, Lucas M, Lynn DJ, Manning L, McPhate MN, Perrett KP, Post JJ, Prat-Aymerich C, Quinn MLE, Richmond PC, Wood NJ, Messina NL, Curtis N; BRACE Trial Consortium Group. Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial. Journal of Infection 2024;89:106267. doi: 10.1016/j.jinf.2024.106267. [Full text]

Reynolds R, Tay E, Dymock M, Deng L, Glover C, Lopez LK, Huang YA, Cashman P, Leeb A, Marsh JA, Snelling T, Wood N, Macartney K. Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia. Vaccines 2024;12:971. doi: 10.3390/vaccines12090971. [Full text]

Salter SM, Li D, Trentino K, Nissen L, Lee K, Orlemann K, Peters I, Murray K, Leeb A, Deng L. Safety of four COVID-19 vaccines across primary doses 1, 2, 3 and booster: a prospective cohort study of Australian community pharmacy vaccinations. Vaccines 2022;10:2017. doi: 10.3390/vaccines10122017. [Full text]